Impact of interventions to control and mitigate healthcare-related infections caused by multidrug-resistant bacteria - Integrative revision
DOI:
https://doi.org/10.5902/2236583469797Keywords:
Hospital Infection Control Program, Drug Resistance, Multiple, Bacterial, Patient Safety, Indicators of Morbidity and MortalityAbstract
Health Care Related Infections (HAI) associated with bacterial resistance are one of the biggest problems in global health. About 700,000 deaths will occur and eighty trillion dollars will be spent in the world, until 2050, due to infections with multidrug-resistant bacteria (MDRs). Objectives: To describe the impact of interventions aimed at mitigating HAIs and bacterial resistance on health and economic losses. Methods: Integrative literature review, elaborated by the steps of formulating the research question, search in the databases: Science Direct and Virtual Health Library (BVS/MEDLINE), categorization of studies, evaluation, interpretation of results and synthesis of knowledge. Results: fourteen articles were included, of which 71% reported increased mortality in patients affected by HAI and bacterial resistance, as well as 64% showed an increase in economic costs. The bacteria most associated with resistance were gram-negative 28%, especially Acinetobacter baumannii and gram-positive 14%, especially Staphylococcus aureus. After implementing strategies for the control, mitigation and prevention of HAI and bacterial
resistance, in 64% of the analyzed articles there were clear benefits, such as a reduction in the occurrence of infections by multidrug-resistant bacteria (50%), shorter hospital stays (21%) and reduction of hospital costs (57%). Conclusion: After the implementation of programs and strategies aimed at mitigating HAIs and bacterial resistance, there are associated health and economic benefits. In addition, for these problems to have holistic resolutions, it is essential
that health services have adequate infrastructure. Thus, it will be possible to break the cycle of dissemination of multidrug-resistant strains and mitigate all associated losses.
Downloads
References
Sutherland, N., & Barber, S. (2017). O'Neill Review into Antibiotic Resistance. House of Commons Library, 1(1), 1-41.
van Duin, David, and David L. Paterson. "Multidrug-resistant bacteria in the community: an update." Infectious Disease Clinics 34.4 (2020): 709-722.
Souza, Ester Sena, et al. "Mortalidade e riscos associados a infecção relacionada à assistência à saúde." Texto & Contexto-Enfermagem 24 (2015): 220-228.
da Silva, Kesia Esther, et al. "A high mortality rate associated with multidrug-resistant Acinetobacter baumannii ST79 and ST25 carrying OXA-23 in a Brazilian intensive care unit." PLoS One 13.12 (2018): e0209367.
Nangino, Glaucio de Oliveira, et al. "Impacto financeiro das infecções nosocomiais em unidades de terapia intensiva em hospital filantrópico de Minas Gerais." Revista Brasileira de Terapia Intensiva 24 (2012): 357-361.
Brasil. Ministério da saúde. Portaria n° 529, de 1º de abril de 2013. Institui o programa nacional de segurança do paciente (PNSP). Brasília, DF: Ministério da Saúde, [2013a]. Disponível em: https://www20.anvisa.gov.br/segurancadopaciente/index.php/legislacao/item/portaria -529. Acesso em: 05 Jul. 2020.
Brasil. Ministério da Saúde. Agência Nacional de Vigilância Sanitária (ANVISA). Resolução da Diretoria Colegiada nº 36, de 25 de julho de 2013. Institui ações para a segurança do paciente em serviços de saúde e dá outras providências. Brasília, DF: ANVISA, [2013b]. Disponível em: http://bvsms.saude.gov.br/bvs/saudelegis/anvisa/2013/rdc0036_25_07_2013.html. Acesso em: 05 Jul. 2020.
Lin, Nien-Tsung. "Common antimicrobial-resistant bacteria in nosocomial infections in Taiwan and their prevention." Hu li za zhi The Journal of Nursing 58.4 (2011): 5-10.
Oliveira, Hadelândia Milon de, Cristiane Pavanello Rodrigues Silva, and Rúbia Aparecida Lacerda. "Policies for control and prevention of infections related to healthcare assistance in Brazil: a conceptual analysis." Revista da Escola de Enfermagem da USP 50 (2016): 0505-0511.
Fracarolli, Isabela Fernanda Larios, Samuel Andrade de Oliveira, and Maria Helena Palucci Marziale. "Bacterial colonization and antimicrobial resistance in healthcare workers: an integrative review." Acta Paulista De Enfermagem 30 (2017): 651-657.
Stillwell, Susan B., et al. "Evidence-based practice, step by step: asking the clinical question: a key step in evidence-based practice." AJN The American Journal of Nursing 110.3 (2010): 58-61.
F-OE, Melnyk BM. "Fazendo o caso para a prática baseada em evidências." Prática baseada em evidências em enfermagem & cuidados de saúde: um guia de boas práticas. Filadélfia: Lippincott Williams & Wilkins (2005).
Kossow, Annelene, et al. "Control of multidrug-resistant Pseudomonas aeruginosa in allogeneic hematopoietic stem cell transplant recipients by a novel bundle including remodeling of sanitary and water supply systems." Clinical Infectious Diseases 65.6 (2017): 935-942.
Marks, Suzanne M., Sundari R. Mase, and Sapna Bamrah Morris. "Systematic review, meta-analysis, and cost-effectiveness of treatment of latent tuberculosis to reduce progression to multidrug-resistant tuberculosis." Clinical Infectious Diseases 64.12 (2017): 1670-1677.
Serra-Burriel, Miquel, et al. "Impact of multi-drug resistant bacteria on economic and clinical outcomes of healthcare-associated infections in adults: Systematic review and meta-analysis." PloS one 15.1 (2020): e0227139.
Cara, Abdul Karim Suleman, Syed Tabish Razi Zaidi, and Fatima Suleman. "Cost-effectiveness analysis of low versus high dose colistin in the treatment of multi-drug resistant pneumonia in Saudi Arabia." International Journal of Clinical Pharmacy 40.5 (2018): 1051-1058.
Zhen, Xuemei, et al. "Effect of multiple drug resistance on total medical costs among patients with intra-abdominal infections in China." PLoS One 13.3 (2018): e0193977.
Moccia, Giuseppina, et al. "An alternative approach for the decontamination of hospital settings." Journal of Infection and Public Health 13.12 (2020): 2038-2044.
Tabak, Y. P., et al. "Incremental clinical and economic burden of suspected respiratory infections due to multi-drug-resistant Pseudomonas aeruginosa in the United States." Journal of Hospital Infection 103.2 (2019): 134-141.
Squire, Marietta M., et al. "Cost-Effectiveness of multifaceted built environment interventions for reducing transmission of pathogenic bacteria in healthcare facilities." HERD: Health Environments Research & Design Journal 12.2 (2019): 147-161.
Gagnaire, J., et al. "Carbapenemase-producing Acinetobacter baumannii: An outbreak report with special highlights on economic burden." Médecine et maladies infectieuses 47.4 (2017): 279-285.
Wozniak, Teresa M., Emily J. Bailey, and Nicholas Graves. "Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model." Infection Control & Hospital Epidemiology 40.3 (2019): 320-327.
Dewangan, A., and U. Gaikwad. "Comparative evaluation of a novel fluorescent marker and environmental surface cultures to assess the efficacy of environmental cleaning practices at a tertiary care hospital." Journal of Hospital Infection 104.3 (2020): 261-268.
Giraldi, Guglielmo, et al. "Healthcare-associated infections due to multidrug-resistant organisms: a surveillance study on extra hospital stay and direct costs." Current pharmaceutical biotechnology 20.8 (2019): 643-652.
De Pascale, Gennaro, et al. "Risk factors for mortality and cost implications of complicated intra-abdominal infections in critically ill patients." Journal of Critical Care 50 (2019): 169-176.
López-Montesinos, Inmaculada, et al. "Clinical and economic burden of community-onset multidrug-resistant infections requiring hospitalization." Journal of Infection 80.3 (2020): 271-278.
Murray, Christopher JL, et al. "Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis." The Lancet (2022).
De Oliveira, David MP, et al. "Antimicrobial resistance in ESKAPE pathogens." Clinical microbiology reviews 33.3 (2020): e00181-19.
García, Alexandra Molina, et al. "Infection prevention and care bundles addressing health care-associated infections in neonatal care in low-middle income countries: a scoping review." EClinicalMedicine 44 (2022): 101259.
Meschiari, Marianna, et al. "A five-component infection control bundle to permanently eliminate a carbapenem-resistant Acinetobacter baumannii spreading in an intensive care unit." Antimicrobial Resistance & Infection Control 10.1 (2021): 1-13.
Wassef, Mona, et al. "Care bundle approach to reduce surgical site infections in acute surgical intensive care unit, Cairo, Egypt." Infection and drug resistance 13 (2020): 229.
Mello, Mariana Sanches de, and Adriana Cristina Oliveira. "Overview of the actions to combat bacterial resistance in large hospitals." Revista Latino-Americana de Enfermagem 29 (2021).
Collignon, Peter J., and Scott A. McEwen. "One health—its importance in helping to better control antimicrobial resistance." Tropical medicine and infectious disease 4.1 (2019): 22.
Hernando-Amado, Sara, et al. "Defining and combating antibiotic resistance from One Health and Global Health perspectives." Nature microbiology 4.9 (2019): 1432-1442.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Edlainny Araujo Ribeiro, Ingrid Jordana Bernardes Ferreira, Giovanna Santana Machado
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A Declaração de Direito Autoral e os itens a serem observados podem ser visualizados no seguinte link: http://cascavel.ufsm.br/revistas/ojs-2.2.2/index.php/seculoxxi/information/sampleCopyrightWording
